2235 — MicroTech Medical Hangzhou Co Income Statement
0.000.00%
- HK$1.35bn
- -HK$679.26m
- CNY253.23m
- 21
- 26
- 28
- 11
Annual income statement for MicroTech Medical Hangzhou Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 51.9 | 75.3 | 151 | 174 | 253 |
Cost of Revenue | |||||
Gross Profit | 24.1 | 36.5 | 70.9 | 79.7 | 121 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 130 | 196 | 200 | 208 | 373 |
Operating Profit | -78.3 | -121 | -48.1 | -34.9 | -120 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -78.6 | -121 | -48.2 | -35 | -125 |
Provision for Income Taxes | |||||
Net Income After Taxes | -78.6 | -121 | -48.2 | -35 | -125 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -78.6 | -121 | -48.2 | -35 | -125 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -78.6 | -121 | -48.2 | -35 | -125 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.185 | -0.286 | -0.129 | -0.076 | -0.294 |